Published in Ann Allergy Asthma Immunol on November 01, 2006
Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor. J Exp Med (2009) 1.71
Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol Pract (2014) 1.45
Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement. World Allergy Organ J (2016) 1.40
Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res (2010) 1.19
Cysteinyl leukotrienes and their receptors; emerging concepts. Allergy Asthma Immunol Res (2014) 1.10
Prostaglandin D₂: a dominant mediator of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2014) 1.02
Interleukin-4 in the Generation of the AERD Phenotype: Implications for Molecular Mechanisms Driving Therapeutic Benefit of Aspirin Desensitization. J Allergy (Cairo) (2012) 0.82
Protection of leukotriene receptor antagonist against aspirin-induced bronchospasm in asthmatics. Allergy Asthma Immunol Res (2009) 0.80
A retrospective study of the clinical benefit from acetylsalicylic acid desensitization in patients with nasal polyposis and asthma. Allergy Asthma Clin Immunol (2014) 0.78
Utility of low-dose oral aspirin challenges for diagnosis of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2016) 0.76
Hypersensitivity to Aspirin and other NSAIDs: Diagnostic Approach in Patients with Chronic Rhinosinusitis. Curr Allergy Asthma Rep (2015) 0.75
Platelet-driven leukotriene C4-mediated airway inflammation in mice is aspirin-sensitive and depends on T prostanoid receptors. J Immunol (2015) 0.75
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol (2010) 5.55
Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial. JAMA (2013) 3.94
Single-dose oritavancin in the treatment of acute bacterial skin infections. N Engl J Med (2014) 3.86
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. J Allergy Clin Immunol (2010) 2.98
Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol (2003) 2.26
A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder. J Clin Psychiatry (2014) 2.10
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med (2002) 1.90
Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Ann Allergy Asthma Immunol (2007) 1.77
The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2005) 1.69
Food allergy: a practice parameter update-2014. J Allergy Clin Immunol (2014) 1.60
Excess dampness and mold growth in homes: an evidence-based review of the aeroirritant effect and its potential causes. Allergy Asthma Proc (2007) 1.51
Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res (2010) 1.19
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. Nutr Res (2011) 1.14
The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2002) 1.14
Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2003) 1.12
The safety of celecoxib in patients with aspirin-sensitive asthma. Arthritis Rheum (2002) 1.09
Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2006) 1.00
Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia. Sleep (2011) 0.99
The united allergic airway: connections between allergic rhinitis, asthma, and chronic sinusitis. Am J Rhinol Allergy (2012) 0.98
Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia. Sleep (2010) 0.97
Aspirin sensitivity: implications for patients with coronary artery disease. JAMA (2004) 0.97
Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis. Ann Allergy Asthma Immunol (2008) 0.95
Tedizolid phosphate for the management of acute bacterial skin and skin structure infections: safety summary. Clin Infect Dis (2014) 0.92
Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia. Sleep Med (2011) 0.92
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report. Nutrition (2011) 0.92
Efficacy and safety of doxepin 6 mg in a model of transient insomnia. Sleep Med (2010) 0.92
Improved postprandial glycemic control in patients with type 2 diabetes from subcutaneous injection of insulin lispro with hyaluronidase. Diabetes Technol Ther (2011) 0.91
Selection of patients for aspirin desensitization treatment. J Allergy Clin Immunol (2006) 0.90
Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2003) 0.87
Sensitivity to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol (2002) 0.86
Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2010) 0.86
Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2008) 0.85
Aspirin-exacerbated respiratory disease: burden of disease. Allergy Asthma Proc (2012) 0.85
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel report. J Am Acad Dermatol (2011) 0.85
The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges. J Allergy Clin Immunol (2007) 0.83
Clopidogrel desensitization after drug-eluting stent placement. J Am Coll Cardiol (2007) 0.83
An epidemic of over diagnosing drug allergies. Allergy Asthma Proc (2014) 0.83
Tedizolid phosphate for the management of acute bacterial skin and skin structure infections: efficacy summary. Clin Infect Dis (2014) 0.83
The clinical dilemma of "silent desensitization" in aspirin-exacerbated respiratory disease. Allergy Asthma Proc (2013) 0.82
Aspirin-exacerbated respiratory disease: update on pathogenesis and desensitization. Semin Respir Crit Care Med (2012) 0.81
A placebo- and active-controlled assessment of 6- and 50-mg oral doxepin on cardiac repolarization in healthy volunteers: a thorough QT evaluation. Clin Ther (2011) 0.80
Failure to maintain an aspirin-desensitized state in a patient with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2006) 0.79
Cardiovascular prophylaxis and aspirin "allergy". Immunol Allergy Clin North Am (2012) 0.78
Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2004) 0.78
IDX184 in combination with pegylated interferon-α2a and ribavirin for 2 weeks in treatment-naive patients with chronic hepatitis C. Antivir Ther (2013) 0.78
Does it make sense to "desens"? Aspirin desensitization in the treatment of chronic rhinosinusitis. Curr Allergy Asthma Rep (2006) 0.78
Classification of reactions to nonsteroidal antiinflammatory drugs. Immunol Allergy Clin North Am (2012) 0.77
The Difficult-to-Control Asthmatic: A Systematic Approach. Allergy Asthma Clin Immunol (2006) 0.77
Supraesophageal reflux disease: a review of the literature. Allergy Asthma Proc (2014) 0.77
Does suppression of IL-4 synthesis by aspirin explain the therapeutic benefit of aspirin desensitization treatment? J Allergy Clin Immunol (2010) 0.77
Aspirin desensitization in aspirin-exacerbated respiratory disease. Immunol Allergy Clin North Am (2012) 0.77
Making the call: the diagnosis of acute community-acquired bacterial sinusitis. Am J Rhinol (2006) 0.77
Smoking, environmental tobacco smoke, and aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2011) 0.76
Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2005) 0.76
Aspirin as a cause of pancreatitis in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2012) 0.76
Side effects from daily aspirin treatment in patients with AERD: Identification and management. Allergy Asthma Proc (2011) 0.75
Aspirin-exacerbated respiratory disease: is it in our DNA? Ann Allergy Asthma Immunol (2011) 0.75
Cross-reactivity of cyclooxygenase 2 inhibitors in patients with a history of cutaneous reactions to cyclooxygenase 1 inhibitors. Ann Allergy Asthma Immunol (2005) 0.75
Evidence-based protocols for oral NSAID challenges. J Pediatr (2006) 0.75
Hydroxyurea in the treatment of Churg-Strauss syndrome. J Allergy Clin Immunol (2009) 0.75
Approach to patients with aspirin hypersensitivity and acute cardiovascular emergencies. Allergy Asthma Proc (2013) 0.75
Nonsteroidal anti-inflammatory drug-induced reactions and desensitization. J Asthma (2004) 0.75
Macrolide antibiotics as anti-inflammatory agents. Curr Allergy Asthma Rep (2005) 0.75
Characterization of aspirin allergies in patients with coronary artery disease. Ann Allergy Asthma Immunol (2013) 0.75
Assessment of sensitization risk of a laundry pre-spotter containing protease. Cutan Ocul Toxicol (2011) 0.75
Role of aspirin and other nonsteroidal anti-inflammatory drugs in aspirin-exacerbated respiratory disease. Expert Rev Clin Immunol (2006) 0.75
Sinusitis and chronic progressive exercise-induced cough and dyspnea. Allergy Asthma Proc (2009) 0.75
Methicillin-resistant Staphylococcus aureus pelvic abscesses in a female after gynecologic pelvic surgery. Am J Obstet Gynecol (2011) 0.75